Overview

Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

Status:
Terminated
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out if radiation to the central nervous system (CNS) can be safely omitted with early intensification of chemotherapy and chemotherapy given directly to the CNS. Another purpose is to find out if survival of children with ALL can be improved with risk-directed therapy given on this protocol.
Phase:
Phase 3
Details
Lead Sponsor:
St. Jude Children's Research Hospital
Treatments:
6-Mercaptopurine
Asparaginase
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Etoposide
Idarubicin
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Vincristine